Filing Details
- Accession Number:
- 0001415889-25-012541
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-09 17:01:05
- Reporting Period:
- 2025-05-07
- Filing Date:
- 2025-05-09
- Accepted Time:
- 2025-05-09 17:01:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1730430 | Kiniksa Pharmaceuticals International Plc | KNSA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1741533 | F. John Paolini | 23 Old Bond Street, Third Floor London X0 W1S 4PZ | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Ordinary Share | Acquisiton | 2025-05-07 | 200 | $3.80 | 57,603 | No | 4 | M | Direct | |
Class A Ordinary Share | Disposition | 2025-05-07 | 200 | $27.00 | 57,403 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Ordinary Share | Share Option | Disposition | 2025-05-07 | 200 | $0.00 | 200 | $3.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
65,867 | 2027-06-28 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 16, 2024.
- The option is fully vested and exercisable.